Compare uniQure N.V. Ordinary Shares (QURE) vs Texas Instruments Incorporated (TXN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
uniQure N.V. Ordinary Shares vs Texas Instruments Incorporated — how do they compare? uniQure N.V. Ordinary Shares trades at $20.78 (market cap $1.48B), while Texas Instruments Incorporated trades at $281.15 (market cap $262.88B). The key difference: Texas Instruments Incorporated is far larger — about 177.6× uniQure N.V. Ordinary Shares's market cap, and Texas Instruments Incorporated pays a 2.11% dividend while uniQure N.V. Ordinary Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold uniQure N.V. Ordinary Shares for 0 Days and Texas Instruments Incorporated for 77 Days on average.
| QURE | TXN | |
|---|---|---|
Market Cap | $1.48B | $262.88B |
Volume | 2,488,780 | 5,600,379 |
Sector | Health | Technology |
52-Week High | $70.59 | $332.35 |
52-Week Low | $9.03 | $153.33 |
Typical Hold Time | 0 Days | 77 Days |
Enterprise Value | $728.62M | $269.93B |
Dividend Yield | — | 2.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Texas Instruments (TXN) trades at $281.74, down 0.7% on the day, with a neutral technical signal. The stock shows strong profitability with a 31.11% net income margin and 34.97% ROE, though valuation ratios like a P/E of 43.75 appear elevated. Recent earnings beat expectations in Q1 and Q2 2026, and data center sales growth is a key driver, with news highlighting a 55% year-to-date gain as of September 2026.
The outlook is positive with a consensus price target of $325, implying 15% upside, supported by AI and industrial demand. Risks include high debt-to-asset ratio of 40.61% and semiconductor cycle volatility. Analyst sentiment is mixed but leans bullish with 48% buy ratings.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About uniQure N.V. Ordinary Shares
uniQure N.V. is a biotechnology company that develops gene therapies for rare and severe genetic diseases, marketing HEMGENIX for hemophilia B and advancing its AAV-based miQURE platform in programs such as AMT-130 for Huntington's disease.
Read more on QURE →About Texas Instruments Incorporated
Dallas-based Texas Instruments generates over 95% of its revenue from semiconductors and the remainder from its well-known calculators. Texas Instruments is the world's largest maker of analog chips, which are used to process real-world signals such as sound and power. Texas Instruments also has a leading market share position in processors and microcontrollers used in a wide variety of electronics applications.
Read more on TXN →
